Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2005 1
2010 2
2011 1
2012 1
2013 2
2014 1
2015 1
2018 1
2019 1
2020 1
2022 2
2023 2
2024 1

Text availability

Article attribute

Article type

Publication date

Search Results

14 results

Results by year

Filters applied: . Clear all
Page 1
Long-term Azithromycin in Children With Bronchiectasis Unrelated to Cystic Fibrosis: Treatment Effects Over Time.
Vicendese D, Yerkovich S, Grimwood K, Valery PC, Byrnes CA, Morris PS, Dharmage SC, Chang AB. Vicendese D, et al. Among authors: byrnes ca. Chest. 2023 Jan;163(1):52-63. doi: 10.1016/j.chest.2022.08.2216. Epub 2022 Aug 27. Chest. 2023. PMID: 36030839 Clinical Trial.
BACKGROUND: Following evidence from randomized controlled trials, patients with bronchiectasis unrelated to cystic fibrosis receive long-term azithromycin to reduce acute respiratory exacerbations. However, the period when azithromycin is effective and which patients are l …
BACKGROUND: Following evidence from randomized controlled trials, patients with bronchiectasis unrelated to cystic fibrosis receive long- …
Bronchiectasis: Treatment decisions for pulmonary exacerbations and their prevention.
Bell SC, Elborn JS, Byrnes CA. Bell SC, et al. Among authors: byrnes ca. Respirology. 2018 Nov;23(11):1006-1022. doi: 10.1111/resp.13398. Epub 2018 Sep 11. Respirology. 2018. PMID: 30207018 Free article. Review.
This review considers the evidence for defining and treating pulmonary exacerbations, the approaches for eradication of newly identified airway pathogens and the methods to prevent exacerbations through long-term treatments from a pragmatic practice-based perspective. Area …
This review considers the evidence for defining and treating pulmonary exacerbations, the approaches for eradication of newly identified air …
Thoracic Society of Australia and New Zealand (TSANZ) position statement on chronic suppurative lung disease and bronchiectasis in children, adolescents and adults in Australia and New Zealand.
Chang AB, Bell SC, Byrnes CA, Dawkins P, Holland AE, Kennedy E, King PT, Laird P, Mooney S, Morgan L, Parsons M, Poot B, Toombs M, Torzillo PJ, Grimwood K. Chang AB, et al. Among authors: byrnes ca. Respirology. 2023 Apr;28(4):339-349. doi: 10.1111/resp.14479. Epub 2023 Mar 2. Respirology. 2023. PMID: 36863703 Free PMC article.
Eradicate Pseudomonas aeruginosa when newly detected in lower airway cultures. Individualize therapy for long-term antibiotics, inhaled corticosteroids, bronchodilators and mucoactive agents. ...
Eradicate Pseudomonas aeruginosa when newly detected in lower airway cultures. Individualize therapy for long-term antibiotics, inhal …
Social determinants of respiratory health from birth: still of concern in the 21st century?
Bush A, Byrnes CA, Chan KC, Chang AB, Ferreira JC, Holden KA, Lovinsky-Desir S, Redding G, Singh V, Sinha IP, Zar HJ. Bush A, et al. Among authors: byrnes ca. Eur Respir Rev. 2024 Apr 10;33(172):230222. doi: 10.1183/16000617.0222-2023. Print 2024 Apr 30. Eur Respir Rev. 2024. PMID: 38599675 Free PMC article. Review.
Respiratory symptoms are ubiquitous in children and, even though they may be the harbinger of poor long-term outcomes, are often trivialised. Adverse exposures pre-conception, antenatally and in early childhood have lifetime impacts on respiratory health. ...
Respiratory symptoms are ubiquitous in children and, even though they may be the harbinger of poor long-term outcomes, are often triv …
Cinacalcet: a new treatment for secondary hyperparathyroidism in patients receiving hemodialysis.
Byrnes CA, Shepler BM. Byrnes CA, et al. Pharmacotherapy. 2005 May;25(5):709-16. doi: 10.1592/phco.25.5.709.63595. Pharmacotherapy. 2005. PMID: 15899733 Review.
Cinacalcet's mechanism of action decreases parathyroid hormone, calcium, and phosphorus levels, offering potential advantages over the other treatments for secondary hyperparathyroidism. Additional clinical trials are needed to evaluate the long-term safety and efficacy of …
Cinacalcet's mechanism of action decreases parathyroid hormone, calcium, and phosphorus levels, offering potential advantages over the other …
A decade on: Follow-up findings of indigenous children with bronchiectasis.
McCallum GB, Singleton RJ, Redding GJ, Grimwood K, Byrnes CA, Valery PC, Mobberley C, Oguoma VM, Eg KP, Morris PS, Chang AB. McCallum GB, et al. Among authors: byrnes ca. Pediatr Pulmonol. 2020 Apr;55(4):975-985. doi: 10.1002/ppul.24696. Epub 2020 Feb 25. Pediatr Pulmonol. 2020. PMID: 32096916
OBJECTIVE: The sole prospective longitudinal study of children with either chronic suppurative lung disease (CSLD) or bronchiectasis published in the current era was limited to a single center. We sought to extend this study by evaluating the longer-term clinical and lung …
OBJECTIVE: The sole prospective longitudinal study of children with either chronic suppurative lung disease (CSLD) or bronchiectasis publish …
Extended Versus Standard Antibiotic Course Duration in Children <5 Years of Age Hospitalized With Community-acquired Pneumonia in High-risk Settings: Four-week Outcomes of a Multicenter, Double-blind, Parallel, Superiority Randomized Controlled Trial.
McCallum GB, Fong SM, Grimwood K, Nathan AM, Byrnes CA, Ooi MH, Nachiappan N, Saari N, Morris PS, Yeo TW, Ware RS, Elogius BW, Oguoma VM, Yerkovich ST, de Bruyne J, Lawrence KA, Lee B, Upham JW, Torzillo PJ, Chang AB. McCallum GB, et al. Among authors: byrnes ca. Pediatr Infect Dis J. 2022 Jul 1;41(7):549-555. doi: 10.1097/INF.0000000000003558. Epub 2022 Jun 7. Pediatr Infect Dis J. 2022. PMID: 35476706 Clinical Trial.
Additional research will identify if an extended course provides longer-term benefits....
Additional research will identify if an extended course provides longer-term benefits....
HOspitalised Pneumonia Extended (HOPE) Study to reduce the long-term effects of childhood pneumonia: protocol for a multicentre, double-blind, parallel, superiority randomised controlled trial.
Chang AB, Fong SM, Yeo TW, Ware RS, McCallum GB, Nathan AM, Ooi MH, de Bruyne J, Byrnes CA, Lee B, Nachiappan N, Saari N, Torzillo P, Smith-Vaughan H, Morris PS, Upham JW, Grimwood K. Chang AB, et al. Among authors: byrnes ca. BMJ Open. 2019 Apr 24;9(4):e026411. doi: 10.1136/bmjopen-2018-026411. BMJ Open. 2019. PMID: 31023759 Free PMC article. Clinical Trial.
INTRODUCTION: Early childhood pneumonia is a common problem globally with long-term complications that include bronchiectasis and chronic obstructive pulmonary disease. ...Outcomes from randomised controlled trials (RCTs) on paediatric pneumonia have focused on short-te
INTRODUCTION: Early childhood pneumonia is a common problem globally with long-term complications that include bronchiectasis and chr …
Heated humidification improves clinical outcomes, compared to a heat and moisture exchanger in children with tracheostomies.
McNamara DG, Asher MI, Rubin BK, Stewart A, Byrnes CA. McNamara DG, et al. Among authors: byrnes ca. Respir Care. 2014 Jan;59(1):46-53. doi: 10.4187/respcare.02214. Epub 2013 Jun 13. Respir Care. 2014. PMID: 23764867 Free article. Clinical Trial.
Subjects were assessed for clinical events, clinical examination findings, airway cytokine levels, and airway secretion viscoelasticity. RESULTS: For the short-term study, 15 children were recruited; for the long-term study, 14 children were recruited. Children usin …
Subjects were assessed for clinical events, clinical examination findings, airway cytokine levels, and airway secretion viscoelasticity. RES …
Do New Zealand children with non-cystic fibrosis bronchiectasis show disease progression?
Munro KA, Reed PW, Joyce H, Perry D, Twiss J, Byrnes CA, Edwards EA. Munro KA, et al. Among authors: byrnes ca. Pediatr Pulmonol. 2011 Feb;46(2):131-8. doi: 10.1002/ppul.21331. Epub 2010 Aug 17. Pediatr Pulmonol. 2011. PMID: 20717910
BACKGROUND: There is minimal literature available on the long-term outcome of pediatric non-cystic fibrosis (CF) bronchiectasis. ...
BACKGROUND: There is minimal literature available on the long-term outcome of pediatric non-cystic fibrosis (CF) bronchiectasis. ...
14 results